Basic Information
RNALocate ID: | RLID:11003651 |
RNA Symbol: | hsa-miR-30d-3p |
Localization: | Exosome |
RNA Information
RNA Name: | hsa-miR-30d* |
RNA ID: | miRBase:MIMAT0004551 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 21505438 |
Tissue/Cell Line: | Jurkat-derived T cell line (J77cl20) |
Method: | Microarray |
Description: | Microarray analysis of exosomal miRNAs verses the miRNAs of their respective donor cells. Data are collected from Supplementary Data 1. |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:11003652 | Exosome | Plasma | 23663360 |
RLID-D:11000598 | Microvesicle | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine | |
RLID-D:11001477 | Exosome | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-30d-3p | Lymphoma | MNDR-E-MI-37423 |
MNDR | hsa-miR-30d-3p | Estrogen-receptor positive breast cancer | MNDR-E-MI-37424 |
MNDR | hsa-miR-30d-3p | Progesterone-receptor positive breast cancer | MNDR-E-MI-37425 |
MNDR | hsa-miR-30d-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-37426 |
MNDR | hsa-miR-30d-3p | Her2-receptor positive breast cancer | MNDR-E-MI-37427 |
MNDR | hsa-miR-30d-3p | Breast cancer luminal | MNDR-E-MI-37428 |
MNDR | hsa-miR-30d-3p | Prostate cancer | MNDR-E-MI-37429 |
MNDR | hsa-miR-30d-3p | Gastric cancer | MNDR-E-MI-37430 |
MNDR | hsa-miR-30d-3p | Alzheimer disease | MNDR-E-MI-37431 |
MNDR | hsa-miR-30d-3p | Esophageal carcinoma | MNDR-E-MI-37432 |
MNDR | hsa-miR-30d-3p | Lung cancer | MNDR-E-MI-37433 |
MNDR | hsa-miR-30d-3p | Parkinson disease | MNDR-E-MI-37434 |
MNDR | hsa-miR-30d-3p | Breast cancer | MNDR-E-MI-37435 |
MNDR | hsa-miR-30d-3p | Pancreatic cancer | MNDR-E-MI-37436 |
MNDR | hsa-miR-30d-3p | Melanoma | MNDR-E-MI-37437 |
MNDR | hsa-miR-30d-3p | Nephroblastoma | MNDR-E-MI-37438 |
MNDR | hsa-miR-30d-3p | Colon adenocarcinoma | MNDR-E-MI-37439 |
MNDR | hsa-miR-30d-3p | Familial ovarian cancer | MNDR-E-MI-37440 |
MNDR | hsa-miR-30d-3p | Prostate adenocarcinoma | MNDR-E-MI-37441 |
MNDR | hsa-miR-30d-3p | Glioblastoma | MNDR-E-MI-37442 |
MNDR | hsa-miR-30d-3p | Gastric adenocarcinoma | MNDR-E-MI-37443 |
MNDR | hsa-miR-30d-3p | Lung squamous cell carcinoma | MNDR-E-MI-37444 |
MNDR | hsa-miR-30d-3p | Lung adenocarcinoma | MNDR-E-MI-37445 |
MNDR | hsa-miR-30d-3p | Adrenocortical carcinoma | MNDR-E-MI-37446 |
MNDR | hsa-miR-30d-3p | Thyroid carcinoma | MNDR-E-MI-37447 |
MNDR | hsa-miR-30d-3p | Bladder urothelial carcinoma | MNDR-E-MI-37448 |
MNDR | hsa-miR-30d-3p | Pancreatic adenocarcinoma | MNDR-E-MI-37449 |
MNDR | hsa-miR-30d-3p | Carcinoma renal cell | MNDR-E-MI-37450 |
MNDR | hsa-miR-30d-3p | Kidney renal papillary cell carcinoma | MNDR-E-MI-37451 |
MNDR | hsa-miR-30d-3p | Renal clear cell carcinoma | MNDR-E-MI-37452 |
MNDR | hsa-miR-30d-3p | Lung small cell carcinoma | MNDR-E-MI-37453 |
MNDR | hsa-miR-30d-3p | Stomach carcinoma | MNDR-E-MI-37454 |
MNDR | hsa-miR-30d-3p | Head and neck squamous cell carcinoma | MNDR-E-MI-37455 |
MNDR | hsa-miR-30d-3p | Hepatocellular carcinoma | MNDR-E-MI-37456 |
MNDR | hsa-miR-30d-3p | Familiar ovarian carcinoma | MNDR-E-MI-37457 |
MNDR | hsa-miR-30d-3p | Rheumatoid arthritis | MNDR-E-MI-37458 |
MNDR | hsa-miR-30d-3p | Neuromyelitis optica | MNDR-E-MI-37459 |
MNDR | hsa-miR-30d-3p | Skin cutaneous melanoma | MNDR-E-MI-37460 |
MNDR | hsa-miR-30d-3p | Skin melanoma | MNDR-E-MI-37461 |
MNDR | hsa-miR-30d-3p | Colorectal cancer | MNDR-E-MI-37462 |
MNDR | hsa-miR-30d-3p | Nasopharynx carcinoma | MNDR-E-MI-37463 |
MNDR | hsa-miR-30d-3p | Nasopharyngeal cancer | MNDR-E-MI-37464 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | ACTN1 | Homo sapiens | RR00037667 |
TOP